Results 181 to 190 of about 62,187 (355)

A rare aspect of Crohn\'s disease: Pulmonary involvement in a child

, 2016
Ebru Atike Ongun, Reha Artan, Ayşen Bingöl, Oğuz Dursun   +3 more
openalex   +1 more source

Disease activity classification based on routinely collected blood tests in a prospective paediatric inflammatory bowel disease inception cohort

Journal of Pediatric Gastroenterology and Nutrition, EarlyView.
Abstract We have shown that disease‐activity clusters derived from routine blood tests in administrative data predicted disease outcomes in Crohn's disease (CD). We aimed to validate these findings on a prospective inception cohort. Hierarchical clustering grouped children newly diagnosed with CD by similarities in diagnostic blood tests and fecal ...
Rona Lujan, Oren Ledder, Dotan Yogev, Raffi Lev‐Tzion, Esther Orlanski‐Meyer, Shira Yuval Bar‐Asher, Ibrahim Shamasnah, Eyal Shteyer, Leora Gotesdyner, Mohammad Shawar, Elena Feldman, Gabriella Aschkenasy, Anna Lev, Dan Turner   +13 more
wiley   +1 more source

Vulvar Crohn disease: A case report. [PDF]

SAGE Open Med Case Rep
Kreutz J, Jensen C, Dytoc M.
europepmc   +1 more source

Ustekinumab therapy and serum IL-12/IL-23p40 levels for biologic naïve pediatric-onset Crohn disease [PDF]

, 2019
Akira Shiraishi, Masataka Ishimura, Katsuhide Eguchi, Motoshi Sonoda, Tamami Tanaka, Takehiro Torisu, Shouichi Ohga   +6 more
openalex   +1 more source

Vedolizumab for extraintestinal manifestations in pediatric inflammatory bowel disease: Results from the VedoKids study

Journal of Pediatric Gastroenterology and Nutrition, EarlyView.
Abstract Extraintestinal manifestations (EIMs) manifest in 6%‐47% of patients with inflammatory bowel disease (IBD). Here, we characterize the course of EIMs in pediatric patients receiving vedolizumab included in the VedoKids cohort study. This was a subgroup analysis of the pediatric VedoKids cohort, a multicenter, prospective study of children (aged
Giulia D'Arcangelo, Dan Turner, Oren Ledder, Esther Orlanski‐Meyer, Efrat Broide, Maya Granot, Manar Matar, Seamus Hussey, Anat Yerushalmy‐Feler, Christoph Norden, Erasmo Miele, Marina Aloi   +11 more
wiley   +1 more source

Monoclonal antibodies against the Crohn´s disease - involved pancreatic autoantigen [PDF]

, 1988
Horbach, E., Otte, M., Poschmann, A., Schwarting, K., Scriba, Peter Christian, Stöcker, W.   +5 more
core   +1 more source

Crohn's Disease [PDF]

Postgraduate Medical Journal, 1953
openaire   +2 more sources

Anti‐tumor necrosis factor‐α monotherapy versus combo therapy with immunosuppressant in pediatric inflammatory bowel disease: A real‐life study

Journal of Pediatric Gastroenterology and Nutrition, EarlyView.
Abstract Objectives The aim of the study is to evaluate the efficacy of anti‐tumor necrosis factor (TNF)‐α monotherapy versus combination anti‐TNF‐α and immunosuppressive therapy. Methods A single‐center, retrospective, observational study was conducted on inflammatory bowel disease (IBD) children.
Flora Fedele, Massimo Martinelli, Caterina Strisciuglio, Elena Scarpato, Annamaria Staiano, Erasmo Miele   +5 more
wiley   +1 more source

A Therapeutic Tightrope: Managing Coexisting Crohn Disease and Systemic Lupus Erythematosus With Risankizumab. [PDF]

ACG Case Rep J
AlAwadhi H, Almutawa M, El Ouali S, Koutoubi Z, Memisoglu E, AlDuaij A, Namas R.   +6 more
europepmc   +1 more source

Therapy de‐escalation in pediatric patients with inflammatory bowel disease in remission: Data analysis from the CEDATA registry

Journal of Pediatric Gastroenterology and Nutrition, EarlyView.
Abstract Objectives There are no standardized criteria about stepping down from combination therapy (immunomodulator and tumor necrosis factor (TNF)‐alpha‐inhibitors) in children with inflammatory bowel disease (IBD) to reduce risk for side effects. Our aim was to describe how de‐escalation has been performed in a large pediatric cohort and to find ...
Sila Cekin, Christoph Huenseler, Serdar Cantez, Ilse Broekaert, Jan de Laffolie, CEDATA‐GPGE® Study Group   +5 more
wiley   +1 more source